---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-096921"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2023-12-19T23:59:59+00:00"
generated_at: "2026-06-07T10:44:09.780267+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical restating Q3 2023 financials due to FPA accounting error; prior statements no longer reliable

## Summary
- Audit committee on Dec 14, 2023 concluded Q3 2023 unaudited financials should no longer be relied upon.
- Error in accounting for forward purchase agreement (FPA); prepayment to be reclassified from assets to equity.
- Restatement will also record maturity and share consideration as non-current liabilities.
- Material weakness in internal control over financial reporting as of Sept 30, 2023, previously disclosed.

## SEC filing metadata
- accession: 0001213900-23-096921
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2023-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390023096921/0001213900-23-096921-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390023096921/ea190283-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-096921
- JSON: https://secwatch.observer/filing/0001213900-23-096921.json
- Plain text: https://secwatch.observer/filing/0001213900-23-096921.txt

## Key facts
- Auditor Changes
  Envoy Medical, Inc. reported that prior financial statements should not be relied upon.
  - Action: non reliance
  - Auditor: Grant Thornton LLP
  source text: On December 14, 2023, the audit committee (the "Audit Committee") of the board of directors of Envoy Medical, Inc. (the "Company"), after considering the recommendations of management, concluded that the Company's previously issued unaudited interim financial statements included in the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 (the "Previous Financial Statements" and such period, the "Affected Period"), should no longer be relied upon.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390023096921/0001213900-23-096921-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.